Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.
Irie J, Inagaki E, Fujita M, Nakaya H, Mitsuishi M, Yamaguchi S, Yamashita K, Shigaki S, Ono T, Yukioka H, Okano H, Nabeshima YI, Imai SI, Yasui M, Tsubota K, Itoh H. Irie J, et al. Among authors: fujita m. Endocr J. 2020 Feb 28;67(2):153-160. doi: 10.1507/endocrj.EJ19-0313. Epub 2019 Nov 2. Endocr J. 2020. PMID: 31685720 Free article. Clinical Trial.
Bile acid binding resin improves hepatic insulin sensitivity by reducing cholesterol but not triglyceride levels in the liver.
Tagawa H, Irie J, Itoh A, Kusumoto Y, Kato M, Kobayashi N, Tanaka K, Morinaga R, Fujita M, Nakajima Y, Morimoto K, Sugizaki T, Kawano Y, Yamada S, Kawai T, Watanabe M, Itoh H. Tagawa H, et al. Among authors: fujita m. Diabetes Res Clin Pract. 2015 Jul;109(1):85-94. doi: 10.1016/j.diabres.2015.04.025. Epub 2015 Apr 21. Diabetes Res Clin Pract. 2015. PMID: 25981325
Bile acid binding resin prevents fat accumulation through intestinal microbiota in high-fat diet-induced obesity in mice.
Kusumoto Y, Irie J, Iwabu K, Tagawa H, Itoh A, Kato M, Kobayashi N, Tanaka K, Kikuchi R, Fujita M, Nakajima Y, Morimoto K, Sugizaki T, Yamada S, Kawai T, Watanabe M, Oike Y, Itoh H. Kusumoto Y, et al. Among authors: fujita m. Metabolism. 2017 Jun;71:1-6. doi: 10.1016/j.metabol.2017.02.011. Epub 2017 Feb 27. Metabolism. 2017. PMID: 28521862
Discovery of Novel Bicyclic Pyrazoles as Potent PIP5K1C Inhibitors.
Ochiai K, Seto S, Yajima M, Namie R, Hashimoto N, Fujita M, Yokoyama A, Suezawa T, Matsui H, Tomizawa S, Ishibashi Y, Tanaka Y, Yajima M, Nagasawa M, Ando N. Ochiai K, et al. Among authors: fujita m. ACS Med Chem Lett. 2024 Apr 3;15(5):684-690. doi: 10.1021/acsmedchemlett.4c00090. eCollection 2024 May 9. ACS Med Chem Lett. 2024. PMID: 38746884
5,253 results